Scinai Immunotherapeutics (SCNI) Cash from Investing Activities Growth (3y) (2021 - 2024)
Scinai Immunotherapeutics (SCNI) Cash from Investing Activities Growth (3y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 116.52% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.24% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 32.49% |
| Jun 30, 2024 | 61.72% |
| Mar 31, 2024 | -35.72% |
| Dec 31, 2023 | -39.74% |
| Sep 30, 2023 | 81.86% |
| Jun 30, 2023 | 33.93% |
| Dec 31, 2022 | 35.17% |
| Sep 30, 2022 | 66.67% |
| Mar 31, 2022 | 15.74% |
| Mar 31, 2021 | 26.03% |